Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Adams

Showing results (231-240 of 370) with videos related to

Pageof 37
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 30, 2014
Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, "EdAmyl"Marie Théaudin, Cécile Cauquil, Teresa Antonini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 16, 2023
Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosisPierre Socie, Anouar Benmalek, Cécile Cauquil, et al.
Frontiers in Immunology|August 1, 2024
Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathyMarie-Ghislaine de Goër de Herve, Manon Dekeyser, Houria Hendel-Chavez, et al.
Journal of Autoimmunity|February 22, 2014
Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cellsWenting Huang, Kritika Kachapati, David Adams, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Molecular Genetics and Metabolism|November 20, 2012
Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidaseTyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, et al.
JACC. Advances|August 23, 2025
Vutrisiran in Transthyretin Amyloidosis: A Pooled Safety Analysis of HELIOS-A and HELIOS-BRonald M Witteles, Pablo Garcia-Pavia, Caroline Morbach, et al.
Diabetes|January 18, 2022
Endosomal Sequestration of TLR4 Antibody Induces Myeloid-Derived Suppressor Cells and Reverses Acute Type 1 DiabetesKathryn C S Locker, Kritika Kachapati, Yuehong Wu, et al.
JCI Insight|March 5, 2019
PARP1 inhibition alleviates injury in ARH3-deficient mice and human cellsMasato Mashimo, Xiangning Bu, Kazumasa Aoyama, et al.
Blood|October 24, 2002
Long-lived immature dendritic cells mediated by TRANCE-RANK interactionIsabelle Cremer, Marie-Caroline Dieu-Nosjean, Sylvie Maréchal, et al.
Pageof 37

Showing results (231-240 of 370) with videos related to

Sort By:
Pageof 37
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 30, 2014
Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, "EdAmyl"Marie Théaudin, Cécile Cauquil, Teresa Antonini, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 16, 2023
Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosisPierre Socie, Anouar Benmalek, Cécile Cauquil, et al.
Frontiers in Immunology|August 1, 2024
Frequent detection of IFN-gamma -producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathyMarie-Ghislaine de Goër de Herve, Manon Dekeyser, Houria Hendel-Chavez, et al.
Journal of Autoimmunity|February 22, 2014
Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cellsWenting Huang, Kritika Kachapati, David Adams, et al.
JAMA Neurology|January 13, 2025
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label ExtensionDavid Adams, Jonas Wixner, Michael Polydefkis, et al.
Molecular Genetics and Metabolism|November 20, 2012
Juvenile-onset motor neuron disease caused by novel mutations in β-hexosaminidaseTyler Mark Pierson, Paola A Torres, Bei-Jin Zeng, et al.
JACC. Advances|August 23, 2025
Vutrisiran in Transthyretin Amyloidosis: A Pooled Safety Analysis of HELIOS-A and HELIOS-BRonald M Witteles, Pablo Garcia-Pavia, Caroline Morbach, et al.
Diabetes|January 18, 2022
Endosomal Sequestration of TLR4 Antibody Induces Myeloid-Derived Suppressor Cells and Reverses Acute Type 1 DiabetesKathryn C S Locker, Kritika Kachapati, Yuehong Wu, et al.
JCI Insight|March 5, 2019
PARP1 inhibition alleviates injury in ARH3-deficient mice and human cellsMasato Mashimo, Xiangning Bu, Kazumasa Aoyama, et al.
Blood|October 24, 2002
Long-lived immature dendritic cells mediated by TRANCE-RANK interactionIsabelle Cremer, Marie-Caroline Dieu-Nosjean, Sylvie Maréchal, et al.
Pageof 37